MedPath

Nabriva Therapeutics Ireland DAC

🇮🇪Ireland
Ownership
Subsidiary
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

3

NMPA:2
EMA:1

Drug Approvals

Lefamulin Acetate Tablets

Product Name
信乐妥
Approval Number
国药准字HJ20230127
Approval Date
Nov 14, 2023
NMPA

Lefamulin Acetate Concentrated Solution for Injection

Product Name
信乐妥
Approval Number
国药准字HJ20230128
Approval Date
Nov 14, 2023
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.